Why Elecnor (BME:ENO) is on investors’ radar Elecnor (BME:ENO) has drawn fresh attention after recent share price moves, with ...
CG Oncology develops cretostimogene via rolling BLA, phase 3 PIVOT-006 data in 1H 2026, and $680M cash into 2028. Find out ...
Company now expects to complete enrollment of 150 patients in Q2 2026, with a Phase 3 data readout in mid-2027; Rolling NDA ...
If you ever find a personal or work task daunting, you might just need to rethink how you approach it. Pomodoro apps and ...
After greenlighting 56 novel therapeutics in 2025, four notable applications continue to await the agency’s action after ...
Arvind Subramanian, former Chief Economic Advisor, and Devesh Kapur, Professor of South Asian Studies at Johns Hopkins ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback